Physician profile
James E Stone
NPI 1417066226
$60,748.02
in general payments reported to CMS, 2019-2025
37 companies · $5,537 in 2025
The $5,537 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $1,694 · 2021: $11K · 2022: $3,277 · 2023: $4,329 · 2024: $1,268 · 2025: $5,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,939 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Consulting Fee: $2,000 · Travel and Lodging: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,938.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $1,695.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $47,206.21 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Biotronik INC. | $8,089.16 | 2019-2025 | Acticor 7 Vr-T Dx, Solia, Amvia Edge |
| Biosense Webster, INC. | $2,000.28 | 2022 | |
| Abbott Laboratories | $1,270.12 | 2019-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Medtronic, INC. | $234.39 | 2022-2025 | Micra, Corevalve Evolut R |
| Abiomed | $218.79 | 2024-2025 | Impella |
| Impulse Dynamics (USA) INC. | $199.77 | 2022 | |
| Alnylam Pharmaceuticals INC. | $156.16 | 2021-2025 | Amvuttra, Onpattro |
| Inspire Medical Systems, INC. | $139.16 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $113.68 | 2019-2023 | |
| Pfizer INC. | $112.60 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $104.39 | 2019-2024 | |
| Atricure, INC. | $89.83 | 2021-2023 | |
| Acutus Medical, INC. | $81.64 | 2019 | |
| Thrombolex, INC. | $68.71 | 2025 | Bashir Endovascular Catheter |
Show all 36 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.